grant
THIS TASK ORDER IS FOR THE PROTEOMIC CHARACTERIZATION LABORATORY.
Organization LEIDOS BIOMEDICAL RESEARCH, INC.Location FREDERICK, UNITED STATESPosted 25 Sept 2021Deadline 24 Sept 2028
NIHUS FederalResearch GrantFY2025AccelerationAffinityAfter CareAfter-TreatmentAftercareAntibodiesAssayBenchmarkingBest Practice AnalysisBioassayBiologicalBiological AssayBiomedical ResearchBiopsy SampleBiopsy SpecimenBody TissuesCancersClinicalClinical Trials NetworkCommunitiesCompetenceComplex MixturesCore BiopsyCore Needle BiopsyCustomExperimental TherapiesInvestigational TherapiesInvestigational TreatmentsLaboratoriesLiquid substanceMalignant NeoplasmsMalignant TumorMass Photometry/Spectrum AnalysisMass SpectrometryMass SpectroscopyMass SpectrumMass Spectrum AnalysesMass Spectrum AnalysisMeasurementMethodsModelingMolecularNCI OrganizationNational Cancer InstitutePDX modelPatient derived xenograftPatientsPeptidesPharmacodynamicsPhosphorylationPost-Translational Modification Protein/Amino Acid BiochemistryPost-Translational ModificationsPost-Translational Protein ModificationPost-Translational Protein ProcessingPosttranslational ModificationsPosttranslational Protein ProcessingProtein ModificationProtein PhosphorylationProteinsProteomeProteomicsReagentResearch InstituteResearch SpecimenSpecimenStandardizationTissuesTranslatinganti-cancer researchassay developmentbenchmarkbiologiccancer researchcustomsdepositoryearly clinical trialearly phase clinical trialexperimental therapeutic agentsexperimental therapeuticsfluidgenome analysisimprovedliquidmalignancymass spectrometermethod developmentneoplasm/cancerpatient derived xenograft modelpost treatmentprogramsproteogenomicsrepositorytranslational cancer researchtreatment effecttumor
Description preview
The National Cancer Institute (NCI)’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) is a national effort to accelerate the understanding of the molecular basis of cancer through the application of large-scale proteome and genome analysis, or proteogenomics. NCI supports an Antibody Program, operated by Leidos Biomedical Research, Inc…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click